AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Letroma 2.5 Tablet

Prescription Icon
Prescription Required

Marketer

Varima Pharma Pvt Ltd

Salt Composition

Letrozole (2.5mg)

Overview Letroma 2.5 Tablet

Postmenopausal women with breast cancer may find relief with Letroma 2.5mg tablets. This medication can be administered independently or alongside other therapies like surgery or radiotherapy. In advanced breast cancer, it helps impede metastasis. Letroma 2.5mg tablets can be ingested with or without food, always adhering to the physician's prescribed dosage and duration for optimal results. Dosage frequency varies depending on the treatment goal, determined by your doctor to manage your symptoms effectively. Continue the medication for the prescribed period. Commonly reported side effects include hot flushes, tiredness, excessive perspiration, and elevated cholesterol (hypercholesterolemia). Report any concerning side effects to your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or a history of osteoporosis. Complete disclosure of all current medications is crucial, as interactions can impact Letroma's efficacy. Pregnant or breastfeeding patients should consult their doctor. Blood tests to assess vitamin D levels and bone density may be conducted before and during treatment.

Uses of Letroma 2.5 Tablet

Managing breast cancer

Major Benefits of Letroma 2.5 Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letroma 2.5 Tablet can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Letroma 2.5 Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letroma 2.5 Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letroma 2.5 Tablets can be consumed with or without food, though consistent timing is recommended.

How Letroma 2.5 Tablet works:

Letroma 2.5mg tablets function as an aromatase inhibitor, reducing the body's estrogen production. This lowered estrogen level can impede or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Letroma 2.5 Tablet and alcohol consumption.

PregnancyPregnancyUNSAFE

Use of Letroma 2.5 Tablet is strongly contraindicated during pregnancy. Pregnant individuals should consult their physician; research in both animal models and pregnant women reveals substantial risks to fetal development.

Breast feedingBreast feedingUNSAFE

Use of Letroma 2.5 Tablet while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from the medication.

DrivingDrivingUNSAFE

Taking Letroma 2.5 Tablet might reduce awareness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Individuals with kidney disease can generally use Letroma 2.5 Tablet without altering the dosage. However, data on its use in patients with end-stage renal disease is scarce. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Letroma 2.5 mg tablets; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Letroma 2.5 Tablet :

Should you forget a Letroma 2.5 Tablet dose, take it immediately. If your next dose is nearly due, however, omit the missed dose and resume your usual dosage schedule. Never take a double dose.

Facts to Know About Letroma 2.5 Tablet

LabelValue
Chemical Type Diphenylmethane-based compound
Developing Habits No.
Treatment Category Cancer Therapeutics

FAQs on Letroma 2.5 Tablet

Letroma 2.5 Tablets are an aromatase inhibitor, typically prescribed for postmenopausal women with breast cancer, including those whose menstruation ceased due to surgery or chemotherapy.
Letroma 2.5 Tablets function as an aromatase inhibitor, an anti-estrogen medication. By blocking the aromatase enzyme, it lowers the body's estrogen production. Since estrogen fuels the growth of certain breast cancers—termed "estrogen-dependent cancers"—reducing estrogen levels can help prevent cancer progression.
For advanced breast cancer or cancer that has spread, continue Letroma 2.5 Tablet until tumor progression. Following tamoxifen or surgery, take Letroma 2.5 Tablet for five years or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Letroma 2.5 Tablet followed by three years of tamoxifen may be used.
While irbesartan and Letroma 2.5 Tablet can be taken together, monitor your blood pressure closely as Letroma 2.5 Tablet may raise it. Consult your doctor if blood pressure management becomes difficult.
While rare, Letroma 2.5 Tablet may cause cataracts. Consult your doctor promptly if you experience blurred vision or eye irritation.
Experiencing hot flushes may indicate a common side effect of Letroma 2.5 Tablet, linked to decreased estrogen. These usually lessen as your body adapts, but may persist throughout treatment, subsiding months afterward. Severe discomfort warrants a doctor's consultation for potential remedies.
While rare, Letroma 2.5 Tablet may cause serious side effects such as stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Letroma 2.5 Tablet can lead to bone thinning (osteoporosis) from reduced estrogen. Your doctor might monitor your bone density before, during, and after treatment to detect osteoporosis.
The Ministry of Health and Family Welfare restricts Letroma 2.5 Tablet use to ovulation induction in women with anovulatory infertility.
Letroma 2.5 Tablet
346